These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23152006)

  • 1. Drug-induced interstitial lung disease (DILD) in molecular targeted therapy.
    Gemma A
    Int J Clin Oncol; 2012 Dec; 17(6):533. PubMed ID: 23152006
    [No Abstract]   [Full Text] [Related]  

  • 2. Current status of DILD in molecular targeted therapies.
    Saito Y; Gemma A
    Int J Clin Oncol; 2012 Dec; 17(6):534-41. PubMed ID: 23152005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interstitial lung disease associated with chemotherapy and molecularly-targeted drug: diagnosis and management].
    Saito Y; Gemma A
    Gan To Kagaku Ryoho; 2011 Dec; 38(13):2531-7. PubMed ID: 22189216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of and risk factors for interstitial lung disease induced by chemotherapy for lung cancer.
    Sakurada T; Kakiuchi S; Tajima S; Horinouchi Y; Okada N; Nishisako H; Nakamura T; Teraoka K; Kawazoe K; Yanagawa H; Nishioka Y; Minakuchi K; Ishizawa K
    Ann Pharmacother; 2015 Apr; 49(4):398-404. PubMed ID: 25565405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-induced interstitial lung disease].
    Gemma A
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1668-70. PubMed ID: 18931568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Strategy of therapy for interstitial lung disease due to chemotherapeutic drugs or radiation].
    Ishioka S
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():432-8. PubMed ID: 9369919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side effects and good effects from new chemotherapeutic agents. Case 1. Gefitinib-induced interstitial fibrosis.
    Nagaria NC; Cogswell J; Choe JK; Kasimis B
    J Clin Oncol; 2005 Apr; 23(10):2423-4. PubMed ID: 15800334
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight.
    Min JH; Lee HY; Lim H; Ahn MJ; Park K; Chung MP; Lee KS
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1099-109. PubMed ID: 21913033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemetrexed and interstitial lung disease.
    Adhikari B; Dongol RM; Baral D; Hewett Y; Shah BK
    Acta Oncol; 2016; 55(4):521-2. PubMed ID: 26366501
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-induced Interstitial Lung Disease Has the Same Degree of Risk for Mortality as Old Age in Patients With Lung Cancer.
    Iwashita K; Mizuno T; Kumazawa S; Imaizumi K; Yamada S
    Anticancer Res; 2021 Mar; 41(3):1707-1711. PubMed ID: 33788769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of Risk Factors for Side Effects and the Establishment of Supportive Therapy during Cancer Chemotherapy].
    Sakurada T
    Yakugaku Zasshi; 2018; 138(11):1363-1370. PubMed ID: 30381644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial Lung Disease Induced by Pazopanib Treatment.
    Ide S; Sakamoto N; Hara S; Hara A; Kakugawa T; Nakamura Y; Futsuki Y; Izumikawa K; Ishimatsu Y; Yanagihara K; Mukae H
    Intern Med; 2017; 56(1):79-83. PubMed ID: 28050004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world.
    Kaku S; Horinouchi H; Watanabe H; Yonemori K; Okusaka T; Boku N; Yamazaki N; Kawai A; Ohe Y; Kusumoto M
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1737-1746. PubMed ID: 35129672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe acute interstitial pnuemonia and gefitinib.
    Sumpter K; Harper-Wynne C; O'Brien M; Congleton J
    Lung Cancer; 2004 Mar; 43(3):367-8. PubMed ID: 15165098
    [No Abstract]   [Full Text] [Related]  

  • 15. Erlotinib-induced acute interstitial lung disease associated with extreme elevation of the plasma concentration in an elderly non-small-cell lung cancer patient.
    Tsubata Y; Hamada A; Sutani A; Isobe T
    J Cancer Res Ther; 2012; 8(1):154-6. PubMed ID: 22531540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-small cell lung cancer: 2) Epidermal growth factor receptor inhibitor and severe adverse phenomena].
    Kudo S; Yoshimura A; Genma A
    Nihon Naika Gakkai Zasshi; 2003 Jul; 92(7):1291-5. PubMed ID: 12924276
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy-induced pulmonary toxicity in lung cancer patients.
    Ryu JH
    J Thorac Oncol; 2010 Sep; 5(9):1313-4. PubMed ID: 20736803
    [No Abstract]   [Full Text] [Related]  

  • 18. Sudden onset of interstitial lung disease induced by gefitinib in a lung cancer patient with multiple drug allergy.
    Aoe K; Hiraki A; Murakami T; Maeda T; Umemori Y; Katayama H; Eda R; Takeyama H
    Anticancer Res; 2005; 25(1B):415-8. PubMed ID: 15816604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adverse events of molecular targeting drugs in oncology].
    Gemma A
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():761-5. PubMed ID: 23156611
    [No Abstract]   [Full Text] [Related]  

  • 20. Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylate.
    Ohnishi K; Sakai F; Kudoh S; Ohno R
    Leukemia; 2006 Jun; 20(6):1162-4. PubMed ID: 16598305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.